• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS; ILIAC COVERED STENT, ARTERIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS; ILIAC COVERED STENT, ARTERIAL Back to Search Results
Model Number BXAL083902A
Device Problem Human-Device Interface Problem (2949)
Patient Problems Calcium Deposits/Calcification (1758); Perforation of Vessels (2135)
Event Date 10/05/2021
Event Type  Death  
Event Description
The following was reported to gore: on (b)(6) 2021, a female patient required treatment due to aorto-iliac disease.As reported, the patient's vessels were calcified.A covered endovascular reconstruction of aortic bifurcation (cerab) procedure was performed using multiple gore® viabahn® vbx balloon expandable endoprostheses (vbx devices).The first vbx device (11x59) was placed in the aorta and post dilated to 16mm in the proximal section.Next, two vbx devices (8l x 39) were inserted and deployed using a kissing technique configuration into the iliac arteries.Two vbx devices (8x39) were also implanted at the overlap.Images reviewed showed good results.Using the ivus, it was observed the right side was not fully expanded.Two 10mm balloons were placed into the iliac arteries that had the 8lx39 vbx devices.Images revealed on the left side, piece of calcium appeared to have pushed through the left common iliac vbx device as bleeding was coming through the stent.Additional vbx devices (8lmm x 79mm) were deployed to reline the vbx devices.The patient¿s condition was stabilized and was transferred to surgery.During the surgical conversion, it was found the patient had more issues than the focal bleeding.Ultimately, patient expired with bleeding from the left common iliac artery.Two 8x29 vbx devices were utilized in each common iliac artery, which connected to the 8x39 vbx devices before the 8x79 vbx devices were deployed.Two 8x39 vbx device lot/serial numbers were entered as it is unknown which device was placed in the left common iliac artery.
 
Manufacturer Narrative
Cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.Patient weight was requested, but not made available.(b)(4): review of device manufacturing record history is currently in progress.The affected devices remain implanted / were not returned to gore.Therefore, direct product analysis was not possible.
 
Manufacturer Narrative
H6 - code 213: review of device manufacturing record history confirmed device met pre-release specifications.Further investigation was not possible as device remains implanted and no images were provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS
Type of Device
ILIAC COVERED STENT, ARTERIAL
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
genevieve begay
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key12754232
MDR Text Key280440389
Report Number2017233-2021-02513
Device Sequence Number1
Product Code PRL
UDI-Device Identifier00733132637829
UDI-Public00733132637829
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
P160021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/18/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/04/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/23/2024
Device Model NumberBXAL083902A
Device Catalogue NumberBXAL083902A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/06/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/23/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? Yes
Type of Device Usage A
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age79 YR
Patient SexFemale
-
-